At a glance
ClinicalIndex Comparison RecordN/ACompleted· 85 enrolled
Drug / intervention
Misoprostol +1 moredrug
Likely dose
Misoprostol 400 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Control Trial of Misoprostol Versus Placebo for Cervical Priming in IUD Insertion for Nulliparous Women
In Brief
A clinical study evaluating Misoprostol and Placebo for Pain. Completed, enrolled 85 participants.
Detailed Summary
The purpose of this study is to see if using misoprostol makes the intrauterine device insertion easier and less painful in women who have never had a baby.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedMar 2011
Primary CompletionFeb 2013
Study CompletionMar 2013
TodayJul 2026
First PostedMar 2, 2011
Enrollment StartFeb 1, 2011
Primary CompletionFeb 1, 2013
Study CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.3 years ago
Interventions
Misoprostoldrug
400 micrograms inserted buccally or vaginally, per the participants desire prior to the IUD insertion.
Placebodrug
Pills which are identical to the study drug in appearance, taste, and smell.